QT-019C
QH-HH-03
Phase 1 small_molecule active
Quick answer
QT-019C for Neuromyelitis Optica Spectrum Disorders is a Phase 1 program (small_molecule) at Tianjin Huanhu Hospital with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tianjin Huanhu Hospital
- Indication
- Neuromyelitis Optica Spectrum Disorders
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active